Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.56%
0%
-12.56%
6 Months
-14.22%
0%
-14.22%
1 Year
-26.63%
0%
-26.63%
2 Years
-8.94%
0%
-8.94%
3 Years
-20.18%
0%
-20.18%
4 Years
-63.59%
0%
-63.59%
5 Years
-90.99%
0%
-90.99%
Mercator Medical SA for the last several years.
Risk Adjusted Returns v/s 
News

Mercator Medical SA's Valuation Upgrade Signals Complex Financial Landscape Ahead
Mercator Medical SA has recently seen a revision in its valuation grade to very attractive, reflecting a favorable assessment of its financial standing. Despite being loss-making, the company reported a significant profit increase of 65% over the past year, highlighting a complex financial landscape with both opportunities and challenges.
Read More Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-14.85%
EBIT Growth (5y)
-148.22%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
0.58
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
57.64%
ROE (avg)
25.78%
Valuation key factors
Factor
Value
P/E Ratio
77
Industry P/E
Price to Book Value
0.43
EV to EBIT
-8.50
EV to EBITDA
62.40
EV to Capital Employed
0.27
EV to Sales
0.33
PEG Ratio
1.77
Dividend Yield
8.87%
ROCE (Latest)
-3.22%
ROE (Latest)
0.56%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
147.60
149.20
-1.07%
Operating Profit (PBDIT) excl Other Income
5.40
2.90
86.21%
Interest
0.10
0.00
Exceptional Items
-1.80
54.20
-103.32%
Consolidate Net Profit
30.60
66.20
-53.78%
Operating Profit Margin (Excl OI)
-6.80%
-21.80%
1.50%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is -1.07% vs 6.95% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is -53.78% vs 361.66% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
542.50
469.10
15.65%
Operating Profit (PBDIT) excl Other Income
-1.50
-50.50
97.03%
Interest
0.40
1.10
-63.64%
Exceptional Items
57.50
-8.00
818.75%
Consolidate Net Profit
49.80
-22.80
318.42%
Operating Profit Margin (Excl OI)
-45.70%
-154.80%
10.91%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 15.65% vs -13.53% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 318.42% vs 88.05% in Dec 2023
About Mercator Medical SA 
Mercator Medical SA
Retailing
Mercator Medical SA is a Poland-based company engaged in medical supplies industry. The Company manufactures medical gloves and distributes disposable medical materials. It produces medical, latex, synthetic, surgical, diagnostic sterile, examination and protective and household gloves. Its dressing products line includes gauze dressing products, non-woven fabric dressing, medical adhesive tapes, surgical dressing, among others. In addition, the Company provides drapes such as bed sheets, sets, as well as apparel, including caps, masks, gowns, among others. It operates through subsidiaries: Mercator Medical Kft, Mercator Medical srl, Merkator Medikal TOB, Mercator Medical (Thailand) Ltd and VIVOFT LLP.
Company Coordinates 
Company Details
Heleny Modrzejewskiej 30 , KRAKOW None : 31-327
Registrar Details






